论文信息 - Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis. - 字舞流文

Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis.

Dustin J Maly | W. Hol | M. Parsons | E. Merritt | D. Kempf | A. DeRocher | W. V. Van Voorhis | K. Marsh | N. Isoherranen | K. Ojo | Kasey L. Rivas | V. Carruthers | Gail M. Freiberg | Latha Kallur Siddaramaiah | J. Zambriski | E. Fan | Zhongsheng Zhang | Ryan Choi | L. Barrett | Matthew A Hulverson | R. Vidadala | Wenlin Huang | J. S. Doggett | T. Schultz | S. Scheele | I. Bruzual | Matthew A. Hulverson | J. Doggett | Tracey L. Schultz